Survival of patients with pathologically proven multiple system atrophy
A meta-analysis
Abstract
Article abstract-A systematic review of the neurologic literature identified 433 cases of pathologically proven multiple system atrophy over a 100-year period. Earlier case reports included patients younger in age with more frequent cerebellar involvement. Mean age of onset was 54.2 years (range 31 to 78) and survival was 6.2 years (range 0.5 to 24). Survival analysis showed a secular trend from a median duration of 4.9 years for publications between 1887 and 1970 to 6.8 years between 1991 and 1994. Older age of onset was associated with shorter survival; the hazard ratio for patients with onset after 60 years was 1.8 (95% CI 1.4 to 2.3) compared with patients between 31 and 49 years. Cerebellar features were associated with marginally increased survival (6.1 years versus 5.4 years; p = 0.04). There were no differences in survival according to gender, parkinsonian, or pyramidal features or whether the patient was classified as striatonigral degeneration or olivopontocerebellar atrophy type. These results demonstrate the poor prognosis for patients with multiple system atrophy but may be biased toward the worst cases. Future research needs to recruit more representative samples.
NEUROLOGY 1997;48: 384-393
Get full access to this article
View all available purchase options and get full access to this article.
REFERENCES
1.
Wenning GK, Ben-Shlomo Y, Magalhes M, Daniel SE, Quinn NP. Clinical features and natural history of multiple system atrophy: an analysis of 100 cases. Brain 1994;117:835-845.
2.
Magalhaes M, Wenning GK, Daniel SE, Quinn NP. Autonomic dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson's disease-a retrospective comparison. Acta Neurol Scand 1995;91:96-102.
3.
Schulz JB, Klockgether T, Petersen D, et al. Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with IBZM-SPECT. J Neurol Neurosurg Psychiatry 1994;57:1047-1056.
4.
Quinn N. Multiple system atrophy. In: Marsden CD, Fahn S, eds. Movement disorders 3. 1st ed. London: Butterworths and Heinemann, 1994;262-281.
5.
Wenning GK, Tison F, Ben-Shlomo Y, Daniel SE, Quinn NP. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord (in press).
6.
Gilman S, Quinn NP. The relationship of multiple system atrophy to sporadic olivopontocerebellar atrophy and other forms of idiopathic late onset cerebellar atrophy. Neurology 1996;46:1197-1199.
7.
Collett D. Modelling survival data in medical research. London: Chapman and Hall, 1994:1-347.
8.
Wenning GK, Ben-Shlomo Y, Magalhaes M, Daniel SE, Quinn NP. Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry 1995;58:160-166.
9.
Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
10.
Ben-Shlomo Y, Wenning G, Quinn N. Gender differences in the survival of patients with multiple system atrophy: real or artifact? New Trends Clin Neuropharmacol 1994;8:206.
11.
Dejerine J, Thomas A. L'atrophie olivo-ponto-cerebelleuse. Nouv Iconogr Salpetriere 1900;13:330-370.
12.
Shy GM, Drager GA. A neurological syndrome associated with orthostatic hypotension. Arch Neurol 1960;2:511-527.
13.
Adams RD, van Bogaert L, van der Eecken H. Degenerescences nigro-striees et cerebello-nigro-striees. Psychiat Neurol 1961;142:219-259.
Information & Authors
Information
Published In
Neurology®
Volume 48 • Number 2 • February 1997
Pages: 384-393
Copyright
Copyright 1997 by Advanstar Communications Inc.
Publication History
Published online: February 1, 1997
Published in print: February 1997
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Diagnostic Effectiveness of [123I]Ioflupane Single Photon Emission Computed Tomography (SPECT) in Multiple System Atrophy, Journal of Clinical Medicine, 12, 10, (3478), (2023).https://doi.org/10.3390/jcm12103478
- Sex differences in alpha-synucleinopathies: a systematic review, Frontiers in Neurology, 14, (2023).https://doi.org/10.3389/fneur.2023.1204104
- Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting, Neurology, 90, 2, (74-82), (2023)./doi/10.1212/WNL.0000000000004798
- Do published criteria improve clinical diagnostic accuracy in multiple system atrophy?, Neurology, 59, 10, (1486-1491), (2023)./doi/10.1212/01.WNL.0000028690.15001.00
- A case report and literature review of possible multiple system atrophy–parkinsonian type with cholinergic deficiency, CNS Neuroscience & Therapeutics, 29, 8, (2384-2387), (2023).https://doi.org/10.1111/cns.14243
- Exploring the mechanism of astragalus membranaceus in the treatment of multiple system atrophy based on network pharmacology and molecular docking, Medicine, 102, 5, (e32523), (2023).https://doi.org/10.1097/MD.0000000000032523
- Development and Validation of a Prognostic Model to Predict Overall Survival in Multiple System Atrophy, Movement Disorders Clinical Practice, (2023).https://doi.org/10.1002/mdc3.13822
- Epidemiology of atypical parkinsonian syndromes, Tzu Chi Medical Journal, 34, 2, (169), (2022).https://doi.org/10.4103/tcmj.tcmj_218_20
- Diagnosing Premotor Multiple System Atrophy, Neurology, 99, 11, (e1168-e1177), (2022)./doi/10.1212/WNL.0000000000200861
- Multiple system atrophy: α-Synuclein strains at the neuron-oligodendrocyte crossroad, Molecular Neurodegeneration, 17, 1, (2022).https://doi.org/10.1186/s13024-022-00579-z
- See more
Loading...
View Options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to get full access to it.